Companies /Healthcare

Baxter International Inc

NYSE: BAX Medical Instruments & Supplies
$25.49
▲ $1.27 (+5.24%) today
Markets closed · 12:41am ET

24/7 Wall St. View

BAX at a Glance

Valuation
Market cap
$12.5B
Dividend yield
0.17%
Profitability
Revenue (TTM)
$11.6B
Profit margin
-6.2%
EPS (TTM)
$-1.27
Price
52-week range
$16 – $30
24/7 target
$30.11
Street target
$27.08
Earnings
Q3 2026 EPS
$0.58
vs. $0.52 est.
+11.9%

Headquartered in Deerfield, IL Fiscal year ends December NYSE: BAX baxter.com

About Baxter International

Baxter International Inc. is a global medical technology company serving hospitals, physician offices and other sites of care with connected solutions, medical devices and advanced injectable technologies. Following the sale of its Kidney Care business (now Vantive), Baxter reports two segments.

Medical Products & Therapies contains two divisions:
- Infusion Therapies & Platforms, which absorbed the former Pharmaceuticals segment. It covers sterile IV solutions, infusion systems such as the Novum IQ pump, administration sets, parenteral nutrition, specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding.
- Advanced Surgery, which covers surgical hemostats, sealants and adhesion-prevention products.

Healthcare Systems & Technologies, largely built from the Hillrom acquisition, also contains two divisions:
- Care & Connectivity Solutions, covering smart bed systems, connected monitoring, Global Surgical Solutions and Patient Support Systems.
- Front Line Care, covering diagnostic technologies and respiratory health devices.

The company also supplies Vantive under a Kidney Care manufacturing and supply agreement. Baxter has approximately 37,500 employees, and sales are split roughly evenly between the U.S. and international markets. Updated

Revenue by Segment · Q3 2026
  1. Infusion Therapies & Technologies59%
  2. Care & Connectivity Solutions17%
  3. Advanced Surgery11%
  4. Front Line Care10%

Latest Activity

BAXBaxter International
Q3 2026
EPS
$0.58
est $0.52+11.9%
Revenue
$2.98B
est $2.91B+2.3%

Baxter lifted the floor on full-year adjusted EPS guidance to $2.05, with results topping expectations on both lines.

Quarterly EPS — reported vs estimate

BAX Coverage

Frequently Asked Questions

What does Baxter International do?

Baxter International Inc. is a global medical technology company serving hospitals, physician offices and other sites of care with connected solutions, medical devices and advanced injectable technologies. Following the sale of its Kidney Care business (now Vantive), Baxter reports two segments.

What is the BAX stock price target?

24/7 Wall St.'s 12-month price target for BAX is $30.11, rated Buy. The Wall Street consensus target is $27.08. BAX price prediction →